{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:36:27Z","timestamp":1787016987856,"version":"build-2736575974"},"reference-count":28,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1136\/jnnp-2014-308095","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T23:31:49Z","timestamp":1417217509000},"page":"1137-1142","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["Epstein-Barr virus persistence and reactivation in neuromyelitis optica"],"prefix":"10.1136","volume":"86","author":[{"given":"Saeko","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihito","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-8578","authenticated-orcid":false,"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"key":"key-10.1136\/jnnp-2014-308095-1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308095-2","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1093\/brain\/awp312","article-title":"Does Epstein\u2013Barr virus infection in the brain drive the development of multiple sclerosis?","volume":"132","author":"Pender","year":"2009","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-308095-3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein\u2013Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308095-4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2010.10.013","article-title":"A serological analysis of viral and bacterial infections associated with neuromyelitis optica","volume":"300","author":"Koga","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2014-308095-5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","article-title":"The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes","volume":"34","author":"Sellner","year":"2010","journal-title":"J Autoimmun"},{"key":"key-10.1136\/jnnp-2014-308095-6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp-2012-302925","article-title":"Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status","volume":"84","author":"Yoshimura","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308095-7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308095-8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308095-9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2006.02.008","article-title":"Neuromyelitis optica\u2014Devic's syndrome, update","volume":"5","author":"Mandler","year":"2006","journal-title":"Autoimmun Rev"},{"key":"key-10.1136\/jnnp-2014-308095-10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308095-11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","article-title":"Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain","volume":"37","author":"Reiber","year":"1991","journal-title":"Clin Chem"},{"key":"key-10.1136\/jnnp-2014-308095-12","first-page":"99","article-title":"Cerebrospinal fluid\u2013\u2013physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2014-308095-13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","article-title":"Antiviral immune responses: triggers of or triggered by autoimmunity?","volume":"9","author":"M\u00fcnz","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key-10.1136\/jnnp-2014-308095-14","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.4049\/jimmunol.1101575","article-title":"Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sj\u00f6gren's syndrome","volume":"188","author":"Inoue","year":"2012","journal-title":"J Immunol"},{"key":"key-10.1136\/jnnp-2014-308095-15","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein\u2013Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"key-10.1136\/jnnp-2014-308095-16","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein\u2013Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstr\u00f6m","year":"2004","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308095-17","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein\u2013Barr virus antibody titres and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"key-10.1136\/jnnp-2014-308095-18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/1352458510368051","article-title":"Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis","volume":"16","author":"Castellazzi","year":"2010","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2014-308095-19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/infdis\/135.3.374","article-title":"Endogenous reactivation of Epstein-Barr virus infections","volume":"135","author":"Sumaya","year":"1977","journal-title":"J Infect Dis"},{"key":"key-10.1136\/jnnp-2014-308095-20","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein\u2013Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"key-10.1136\/jnnp-2014-308095-21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0042-6822(92)90253-L","article-title":"The interleukin-10 homolog encoded by Epstein\u2013Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses","volume":"191","author":"Stewart","year":"1992","journal-title":"Virology"},{"key":"key-10.1136\/jnnp-2014-308095-22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2014-308095-23","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"10","author":"Chihara","year":"2011","journal-title":"Proc Natl Acasd Sci USA"},{"key":"key-10.1136\/jnnp-2014-308095-24","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/brain\/awr197","article-title":"Epstein\u2013Barr virus in the multiple sclerosis brain: a controversial issue\u2014report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria","volume":"134","author":"Lassmann","year":"2011","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-308095-25","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"key-10.1136\/jnnp-2014-308095-26","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein\u2013Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-308095-27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/brain\/awp296","article-title":"Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"133","author":"Peferoen","year":"2010","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2014-308095-28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jnnp.64.4.539","article-title":"Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway","volume":"64","author":"Myhr","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2014-308095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T08:01:05Z","timestamp":1717574465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2014-308095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,9,13]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1136\/jnnp-2014-308095"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2014-308095","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,28]]}}}